Literature DB >> 11425769

Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina.

P Bogaty1, P Poirier, S Simard, L Boyer, S Solymoss, G R Dagenais.   

Abstract

BACKGROUND: At one end of the clinical spectrum of coronary artery disease (CAD) are subjects who have had repeated acute ischemic events, and at the other end are those with long-standing angina who have never been unstable. This study tests the hypothesis that a specific biological profile can distinguish these 2 extreme groups and predict acute coronary events. METHODS AND
RESULTS: Blood levels of lipoprotein(a), homocysteine, tissue plasminogen activator, plasminogen activator inhibitor-1, C-reactive protein (CRP), fibrinogen, and von Willebrand factor were compared in 3 groups of 50 subjects each: (1) those with previous multiple acute coronary events, (2) age-matched subjects with >/=3 years of stable angina and no prior acute coronary events, and (3) matched controls without evidence of atherosclerotic disease and a normal coronary angiogram. All subjects were followed for 4.0 years. Lipoprotein(a), homocysteine, tissue plasminogen activator, and plasminogen activator inhibitor-1 were similar in both CAD groups and significantly higher than in the control group. However, compared with subjects with long-standing stable angina, those with previous multiple coronary events had higher values of CRP (5.7+/-5.4 versus 3.0+/-5.2 mg/L, P=0.012), fibrinogen (3.38+/-0.75 versus 2.92+/-0.64 g/L, P=0.001), and von Willebrand factor (1.60+/-0.55 versus 1.25+/-0.36 U/mL, P=0.0003). On follow-up, myocardial infarction and unstable angina occurred in 42% of the group with multiple events, 4% of the stable angina group (P<0.0001), and none of the control subjects. In the 100 patients with CAD, CRP was 4.9 mg/L in those with and 1.8 mg/L in those without new instability (P<0.0001). In a multivariate analysis, only CRP distinguished those with follow-up acute coronary events (adjusted odds ratio 5.9, 95% CI 2.0 to 17.9; P=0.002). A baseline CRP >3.5 mg/L had a relative risk of 7.6 (2.6 to 21.7, P=0.0002) for subsequent acute events.
CONCLUSIONS: An inflammatory biological profile distinguished patients with previous multiple acute coronary events from those with long-standing stable angina and predicted acute coronary instability.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11425769     DOI: 10.1161/01.cir.103.25.3062

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

Review 1.  Inflammation and ageing.

Authors:  U Müller-Werdan
Journal:  Z Gerontol Geriatr       Date:  2007-10       Impact factor: 1.281

2.  The Quebec Heart Institute: 50 years of excellence in cardiology.

Authors:  Gilles R Dagenais; François Philippon; Jean-Pierre Després; Jean G Dumesnil; Paul Cartier; Peter M Bogaty; Michel Lemieux; André Moisan
Journal:  Can J Cardiol       Date:  2007-10       Impact factor: 5.223

3.  Serum n-3 to n-6 polyunsaturated fatty acids ratio correlates with coronary plaque vulnerability: an optical coherence tomography study.

Authors:  Takao Hasegawa; Kenichiro Otsuka; Tomokazu Iguchi; Kenji Matsumoto; Shoichi Ehara; Shinji Nakata; Satoshi Nishimura; Toru Kataoka; Kenei Shimada; Minoru Yoshiyama
Journal:  Heart Vessels       Date:  2013-09-05       Impact factor: 2.037

4.  Heart rate variability and biomarkers of systemic inflammation in patients with stable coronary heart disease: findings from the Heart and Soul Study.

Authors:  Roland von Känel; Robert M Carney; Shoujun Zhao; Mary A Whooley
Journal:  Clin Res Cardiol       Date:  2010-09-21       Impact factor: 5.460

5.  Procoagulant activity, but not number, of microparticles increases with age and in individuals after a single venous thromboembolism.

Authors:  B A L Owen; A Xue; J A Heit; W G Owen
Journal:  Thromb Res       Date:  2010-11-23       Impact factor: 3.944

Review 6.  Obesity and cardiovascular disease.

Authors:  Paul Poirier; Robert H Eckel
Journal:  Curr Atheroscler Rep       Date:  2002-11       Impact factor: 5.113

Review 7.  CRP and the risk of atherosclerotic events.

Authors:  Paolo Calabrò; Enrica Golia; Edward T H Yeh
Journal:  Semin Immunopathol       Date:  2009-05-05       Impact factor: 9.623

8.  Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial).

Authors:  Robert D McBane; Regina M Hardison; Burton E Sobel
Journal:  Am J Cardiol       Date:  2009-11-14       Impact factor: 2.778

9.  Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men.

Authors:  S G Wannamethee; P H Whincup; A G Shaper; A Rumley; L Lennon; G D O Lowe
Journal:  J Thromb Haemost       Date:  2009-08-11       Impact factor: 5.824

10.  Time variability of C-reactive protein: implications for clinical risk stratification.

Authors:  Peter Bogaty; Gilles R Dagenais; Lawrence Joseph; Luce Boyer; Anne Leblanc; Patrick Bélisle; James M Brophy
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.